Projects per year
Personal profile
Education
- 2014-2020 Ph.D., The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2000-2007 M.D., School of Medicine, College of Medicine, Taipei Medical University
Experience
- Attending Physician, Taipei Medical University Hospital
- 2021.01- Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2020.11- Assistant Professor, Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University
- 2019.08-2020.12 Acting Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2014.04-2015.06 Adjunct Attending Physician, Taipei Medical University Hospital
- 2013.04-2014.09 Adjunct Attending Physician, Landseed International Hospital
- 2012.11-2015.06 Attending Physician, Taipei Municipal Wanfang Hospital
Fingerprint
Dive into the research topics where Hsin-Lun Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 7 Finished
-
針對缺氧相關因子與緩激肽B1 受體-水通道蛋白4 訊號軸以克服多形性膠質母細胞瘤放射拮抗性之研究
1/1/22 → 12/31/22
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Stem Cell-Based Approaches and Organotypic Culture System for Dissecting Pathogenic Mechanisms and Establishing Therapeutic Strategies for Inflammatory Bowel Diseases and Gastrointestinal Cancer(3/3)
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
Investigating the Dynamic Change of Genotype and Phenotype in Circulating Tumor Cells and Its Clinical Significance in Cancer Progression
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
利用幹細胞及類器官技術剖析發炎性腸道疾病及消化道癌症的病理機轉並發展治療策略(2/3)
8/1/18 → 7/31/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
Entecavir versus tenofovir on prognosis of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy
Kao, W-Y., Tan, E. C-H., Lee, H-L., Huang, Y-H., Huo, T-I., Chang, C-C., Chiou, J-F., Hou, M-C., Wu, J-C. & Su, C-W., 2023, In: Alimentary Pharmacology and Therapeutics. n/a, n/aResearch output: Contribution to journal › Article › peer-review
-
Feasibility and Toxicity of Interval-Compressed Chemotherapy in Asian Children and Young Adults with Sarcoma: Journal of Personalized Medicine
Huang, J-H., Chen, S-H., Liao, Y-M., Kao, Y-C., Ho, W-L., Chang, H., Tsai, M-L., Lee, H-L., Kuo, C-C., Tseng, S-H., Chang, C-Y., Hsieh, K. L., Lu, L-S., Chen, Y-J., Chiou, J-F., Hsieh, T-H., Liu, Y-R., Hsu, W., Li, W-T., Wu, Y-C., & 8 others, 2023Research output: Other contribution
-
Multidisciplinary team approach for Klippel-Trenaunay syndrome: A case series
Wu, P. C., Chang, C. Y., Ho, W. L., Lee, H. L., Su, Y. Y., Chang, C. J., Hsieh, C. I., Huang, Y. L., Miser, J. S. & Liu, Y. L., 2023, (Accepted/In press) In: Pediatrics and Neonatology.Research output: Contribution to journal › Article › peer-review
Open Access -
NEDD8 promotes radioresistance via triggering autophagy formation and serves as a novel prognostic marker in oral squamous cell carcinoma
Yuan, T. Z., Lin, H. Y., Kuei, C. H., Lin, C. H., Lee, H. H., Lee, H. L., Lu, H. W., Su, C. Y., Chiu, H. W. & Lin, Y. F., Dec 2023, In: Cancer Cell International. 23, 1, 41.Research output: Contribution to journal › Article › peer-review
-
The Titrated Mannitol Improved Central [99mTc] Tc TRODAT-1 Uptake in an Animal Model—A Clinically Feasible Application
Chang, K. W., Chang, P. L., Tsai, C. J., Tsai, Y. J., Wu, P. H., Lee, H. L., Lai, Y. H., Wong, C. Y. O. & Huang, W. S., Feb 2023, In: International journal of molecular sciences. 24, 4, 3773.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I. (Contributor), Lai, G. (Contributor), Chow, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Creator), Li, C. (Contributor), Yan, J. (Contributor), Chuang, S. (Contributor), Whang-Peng, J. (Creator), Bai, K. (Contributor) & Yao, C. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717.v1
Dataset
-
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, G. (Contributor), Li, C. (Contributor), Yeh, C. (Creator), Whang-Peng, J. (Creator), Lee, H. (Contributor), Yao, C. (Contributor), Lai, I. (Contributor), Chuang, S. (Contributor), Chow, J. (Contributor), Bai, K. (Contributor) & Yan, J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d1.v1
Dataset
-
Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer
Wen, Y. (Creator), Lee, L. (Creator), Lin, Y. (Creator), Syu, S. (Creator), Lin, K. (Creator), Fan, Y. (Creator), Lee, H. (Creator), Lai, B. C. H. (Creator) & Shih, H. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.17009635.v1, https://tandf.figshare.com/articles/journal_contribution/Loco-regional_deep_hyperthermia_combined_with_intravesical_Mitomycin_instillation_reduces_the_recurrence_of_non-muscle_invasive_papillary_bladder_cancer/17009635/1
Dataset
-
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Whang-Peng, J. (Creator), Chow, J. (Contributor), Yan, J. (Contributor), Lee, H. (Contributor), Yeh, C. (Creator), Lai, I. (Contributor), Yao, C. (Contributor), Lai, G. (Contributor), Bai, K. (Contributor), Chuang, S. (Contributor) & Li, C. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d3.v1
Dataset
-
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Chuang, S. (Contributor), Lai, I. (Contributor), Yeh, C. (Creator), Yan, J. (Contributor), Yao, C. (Contributor), Whang-Peng, J. (Creator), Li, C. (Contributor), Chow, J. (Contributor), Bai, K. (Contributor), Lee, H. (Contributor) & Lai, G. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d2.v1
Dataset